Discontinued Operations

12 Months Ended

Dec. 31, 2016

Discontinued Operations

Discontinued Operations

3. Discontinued Operations

        On January 30, 2014, the Company sold its entire equity interest in Biolife Cell Bank Dallas, LLC ("Biolife Dallas") back to Biolife Dallas in exchange for nominal consideration and resigned from its position as a director of Biolife Dallas. Additionally, the Company sold all of its equity interests in the two wholly-owned subsidiaries through which it previously owned the equipment and intellectual property assets necessary to conduct the stem cell business conducted by Biolife Dallas. As a result of these transactions, the Company exited the stem cell business.

        In connection with the above transactions, the Company recognized a loss from discontinued operations of $0.2 million during the year ended December 31, 2014. The Company had no corresponding results from discontinued operations for the years ended December 31, 2016 and 2015, respectively.